Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein
- PMID: 15496679
- PMCID: PMC6730110
- DOI: 10.1523/JNEUROSCI.3080-04.2004
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein
Abstract
Accumulation of alpha-synuclein in brain is a hallmark of synucleinopathies, neurodegenerative diseases that include Parkinson's disease. Mice overexpressing alpha-synuclein under the Thy-1 promoter (ASO) show abnormal accumulation of alpha-synuclein in cortical and subcortical regions of the brain, including the substantia nigra. We examined the motor deficits in ASO mice with a battery of sensorimotor tests that are sensitive to alterations in the nigrostriatal dopaminergic system. Male wild-type and ASO mice were tested every 2 months for 8 months for motor performance and coordination on a challenging beam, inverted grid, and pole, sensorimotor deficits in an adhesive removal test, spontaneous activity in a cylinder, and gait. Fine motor skills were assessed by the ability to grasp cotton from a bin. ASO mice displayed significant impairments in motor performance and coordination and a reduction in spontaneous activity as early as 2 months of age. Motor performance and coordination impairments became progressively worse with age and sensorimotor deficits appeared at 6 months. Fine motor skills were altered at 4 months and worsened at 8 months. These data indicate that overexpression of alpha-synuclein induced an early and progressive behavioral phenotype that can be detected in multiple tests of sensorimotor function. These behavioral deficits provide a useful way to assess novel drug therapy in genetic models of synucleinopathies.
Figures
Similar articles
-
Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.Behav Brain Res. 2018 May 2;343:41-49. doi: 10.1016/j.bbr.2018.01.029. Epub 2018 Feb 3. Behav Brain Res. 2018. PMID: 29407413 Free PMC article.
-
A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein.Neurotherapeutics. 2017 Oct;14(4):1107-1119. doi: 10.1007/s13311-017-0544-9. Neurotherapeutics. 2017. PMID: 28585223 Free PMC article.
-
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.Mol Cell Neurosci. 2003 Oct;24(2):419-29. doi: 10.1016/s1044-7431(03)00198-2. Mol Cell Neurosci. 2003. PMID: 14572463
-
Alpha-synuclein and transgenic mouse models.Neurobiol Dis. 2004 Nov;17(2):123-30. doi: 10.1016/j.nbd.2004.07.001. Neurobiol Dis. 2004. PMID: 15474350 Review.
-
Synucleins and their relationship to Parkinson's disease.Cell Tissue Res. 2004 Oct;318(1):163-74. doi: 10.1007/s00441-004-0921-7. Epub 2004 Jul 24. Cell Tissue Res. 2004. PMID: 15503152 Review.
Cited by
-
Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.Exp Neurol. 2013 May;243:57-66. doi: 10.1016/j.expneurol.2013.01.014. Epub 2013 Jan 24. Exp Neurol. 2013. PMID: 23353924 Free PMC article. Review.
-
Quantitative analysis of α-synuclein solubility in living cells using split GFP complementation.PLoS One. 2012;7(8):e43505. doi: 10.1371/journal.pone.0043505. Epub 2012 Aug 22. PLoS One. 2012. PMID: 22927976 Free PMC article.
-
Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.PLoS One. 2011;6(12):e29257. doi: 10.1371/journal.pone.0029257. Epub 2011 Dec 19. PLoS One. 2011. PMID: 22206005 Free PMC article.
-
Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance.Transl Neurodegener. 2020 Sep 24;9(1):38. doi: 10.1186/s40035-020-00217-y. Transl Neurodegener. 2020. PMID: 32972456 Free PMC article.
-
Role of rodent models in advancing precision medicine for Parkinson's disease.Handb Clin Neurol. 2023;193:3-16. doi: 10.1016/B978-0-323-85555-6.00002-3. Handb Clin Neurol. 2023. PMID: 36803818 Free PMC article. Review.
References
-
- Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86: 159-171. - PubMed
-
- Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211. - PubMed
-
- Broida J, Svare B (1982) Strain-typical patterns of pregnancy-induced nest-building in mice: maternal and experiential influences. Physiol Behav 29: 53-57. - PubMed
-
- Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice R, Shults CW, Stoessl AJ (2003) Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Exp Neurol 184[Suppl 1]: 68-79. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous